Mergers & Acquisitions
Guidant can’t slip breach-of-contract charges in Johnson & Johnson suit
Covidien taps integration chief to navigate Medtronic merger
Thoratec inks $75M deal for Apica Cardiovascular
FTC wants more from Zimmer, Biomet on merger
Abiomed acquires German heart pump maker ECP
Johnson & Johnson closes Ortho-Clinical Diagnostics sale
Zimmer, Biomet appoint integration team
Spectranetics closes $230M AngioScore buy
Colorado-based Spectranetics (NSDQ:SPNC) announced today that it consummated its $230 million acquisition of California-based AngioScore, adding that milestones payments are also on the forecast.
Allergan reveals FDA win, lobbies to keep Valeant out
Embattled device maker Allergan (NYSE:AGN) hopes it can keep unwelcome buyer Valeant Pharmaceuticals from getting its hands on the company’s advancing R&D pipeline.